Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03956654
Title A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)
Recruitment Recruiting
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Universitaire Ziekenhuizen Leuven
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole + Ribociclib

Age Groups: senior
Covered Countries


No variant requirements are available.